ATE225512T1 - Abtrennungsverfahren - Google Patents

Abtrennungsverfahren

Info

Publication number
ATE225512T1
ATE225512T1 AT92907150T AT92907150T ATE225512T1 AT E225512 T1 ATE225512 T1 AT E225512T1 AT 92907150 T AT92907150 T AT 92907150T AT 92907150 T AT92907150 T AT 92907150T AT E225512 T1 ATE225512 T1 AT E225512T1
Authority
AT
Austria
Prior art keywords
species
binding
detection
auxiliary
separation method
Prior art date
Application number
AT92907150T
Other languages
English (en)
Inventor
Ramadan Arbi Abuknesha
Mark Philip Byfield
Original Assignee
Marconi Optical Components Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919105921A external-priority patent/GB9105921D0/en
Priority claimed from GB919127346A external-priority patent/GB9127346D0/en
Application filed by Marconi Optical Components Ltd filed Critical Marconi Optical Components Ltd
Application granted granted Critical
Publication of ATE225512T1 publication Critical patent/ATE225512T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/538—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody by sorbent column, particles or resin strip, i.e. sorbent materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G01N33/539—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody involving precipitating reagent, e.g. ammonium sulfate
    • G01N33/541—Double or second antibody, i.e. precipitating antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • G01N33/5438—Electrodes

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Separation By Low-Temperature Treatments (AREA)
AT92907150T 1991-03-20 1992-03-20 Abtrennungsverfahren ATE225512T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB919105921A GB9105921D0 (en) 1991-03-20 1991-03-20 Separation method
GB919127346A GB9127346D0 (en) 1991-12-24 1991-12-24 Separation method
PCT/GB1992/000506 WO1992016838A1 (en) 1991-03-20 1992-03-20 Separation method
CA002106339A CA2106339A1 (en) 1991-03-20 1993-09-16 Separation method

Publications (1)

Publication Number Publication Date
ATE225512T1 true ATE225512T1 (de) 2002-10-15

Family

ID=27169593

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92907150T ATE225512T1 (de) 1991-03-20 1992-03-20 Abtrennungsverfahren

Country Status (7)

Country Link
EP (1) EP0640216B1 (de)
JP (1) JPH06506058A (de)
AT (1) ATE225512T1 (de)
CA (1) CA2106339A1 (de)
DE (1) DE69232801T2 (de)
GB (1) GB2255637B (de)
WO (1) WO1992016838A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9122180D0 (en) 1991-10-18 1991-11-27 Marconi Gec Ltd Separation and analysis
GB9125204D0 (en) * 1991-11-27 1992-01-29 Marconi Gec Ltd Analysis
US5326778A (en) * 1992-03-03 1994-07-05 Research Corporation Technologies, Inc. Conjugates of biotin and deferoxamine for radioimmunoimaging and radioimmunotherapy
EP0653065B1 (de) * 1992-08-03 2002-10-30 Marconi Optical Components Limited Trennverfahren
EP0660935B1 (de) * 1992-08-03 2000-05-24 Gec-Marconi Limited Immunologisches nachweisverfahren unter verwendung von zwei bestimmbaren markern
WO1994007140A1 (en) * 1992-09-18 1994-03-31 Gec-Marconi Limited Separation method
WO1994012878A1 (en) * 1992-11-27 1994-06-09 Gec-Marconi Limited Separation method
US5919712A (en) * 1993-05-18 1999-07-06 University Of Utah Research Foundation Apparatus and methods for multi-analyte homogeneous fluoro-immunoassays
US5677196A (en) * 1993-05-18 1997-10-14 University Of Utah Research Foundation Apparatus and methods for multi-analyte homogeneous fluoro-immunoassays
US5512492A (en) * 1993-05-18 1996-04-30 University Of Utah Research Foundation Waveguide immunosensor with coating chemistry providing enhanced sensitivity
US5532136A (en) * 1993-06-22 1996-07-02 Bionebraska, Inc. Monoclonal antibody assay and kit for detecting metal cations in body fluids
US5459040A (en) * 1993-11-22 1995-10-17 The Regents Of The University Of California Enzyme amplified, complex linked, competitive and non-competitive assays for the detection of metal ions
IL111186A (en) * 1994-10-06 1999-09-22 Univ Bar Ilan Process for the preparation of microspheres and microspheres made thereby
DE19533477C2 (de) * 1995-09-12 1997-10-23 Pharma Beratung Dr Klaus Hoffm Verwendung von Diethylentriaminpentaessigsäure (DTPA) mit immunsuppressiver Wirkung
US6611634B2 (en) 1996-03-19 2003-08-26 University Of Utah Research Foundation Lens and associatable flow cell
DE10217597B4 (de) * 2002-04-19 2008-10-30 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren und Vorrichtung zur elektrochemischen Immobilisierung von Biomolekülen
ES2905054T3 (es) * 2006-11-01 2022-04-06 Ventana Med Syst Inc Haptenos, conjugados de haptenos, composiciones de los mismos y método para su preparación y uso
CN104007262A (zh) * 2014-05-16 2014-08-27 中南林业科技大学 镉离子胶体金免疫层析检测试纸条及其制备方法与应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES471585A1 (es) * 1977-07-15 1979-01-16 Behringwerke Ag Procedimiento para la determinacion de reactivos fc
GB2065298B (en) * 1979-12-12 1985-02-20 Wei Kung Wang Method and apparatus for detecting biological particles by induced signal
JPS56115727A (en) * 1980-02-19 1981-09-11 Kuraray Co Ltd Carrier for immobilizing physiologically active substance
GB8417301D0 (en) * 1984-07-06 1984-08-08 Serono Diagnostics Ltd Assay
US4722892A (en) * 1984-08-31 1988-02-02 Meares Claude F Monoclonal antibodies against metal chelates
GB8422452D0 (en) * 1984-09-05 1984-10-10 Serono Diagnostics Ltd Assay
US4737453A (en) * 1984-12-12 1988-04-12 Immunomedics, Inc. Sandwich immunoassay utilizing a separation specific binding substance
JPS61230058A (ja) * 1985-04-04 1986-10-14 Susumu Kogyo Kk アルブミンの定量法
DE3582172D1 (de) * 1985-06-25 1991-04-18 Progen Biotechnik Gmbh Immuntest zum nachweis von antikoerpern gegen dns.
WO1988002776A1 (en) * 1986-10-10 1988-04-21 Peter Grandics A novel immunoaffinity purification system
EP0282192A1 (de) * 1987-03-09 1988-09-14 Quidel Kompetitiver Immunoassay für Haptene unter Verwendung von gekoppelten Protein-Hapten-Festphasen
CA1313818C (en) * 1987-06-03 1993-02-23 Ross Leon Coppel Nuclear antigen la
JPS6488367A (en) * 1987-09-30 1989-04-03 Japan Chem Res Immobilized antibody
JPH01180456A (ja) * 1988-01-12 1989-07-18 Toyobo Co Ltd リウマチ因子定量用素子および定量法
WO1990001167A1 (en) * 1988-07-19 1990-02-08 E.I. Du Pont De Nemours And Company Porous support system for the immobilization of immunoassay components and assays performed therewith
ES2060634T3 (es) * 1988-10-12 1994-12-01 Biotest Ag Procedimiento para la busqueda e identificacion de anticuerpos eritrociarios con la ayuda del metodo de fases solidas.
DE69027077T2 (de) * 1989-09-08 1996-10-02 Hewlett Packard Co Herstellung einer Festphase, geeignet für spezifische Bindung chemischer Substanzen
JPH10250861A (ja) * 1997-03-11 1998-09-22 Minolta Co Ltd 給紙装置

Also Published As

Publication number Publication date
GB9206082D0 (en) 1992-05-06
GB2255637A (en) 1992-11-11
EP0640216B1 (de) 2002-10-02
EP0640216A1 (de) 1995-03-01
DE69232801D1 (de) 2002-11-07
DE69232801T2 (de) 2003-08-14
JPH06506058A (ja) 1994-07-07
WO1992016838A1 (en) 1992-10-01
GB2255637B (en) 1995-11-15
CA2106339A1 (en) 1995-03-17

Similar Documents

Publication Publication Date Title
DE69232801D1 (de) Abtrennungsverfahren
NO913186L (no) Fremgangsmaate for anvendelse og syntese av peptider.
ES556865A0 (es) Un metodo de inmunoensayo.
DE58902586D1 (de) Immunoassay und -rolymere igg-derivate zur kompensation von stoerfaktoren in immunoassays.
AU6839090A (en) Hepatitis c assay
ATE112059T1 (de) Verfahren zur bestimmung eines analyten.
EP2048505A3 (de) Verfahren zur Früherkennung der Serokonversion eines gegen Hepatitis C-Virus gerichteten Antikörpers
ATE74662T1 (de) Immunoanalysetestverfahren fuer cholesterolepoxide.
DE69230917D1 (de) Verfahren zur detektion von hepatitis c
GB2260609B (en) Separation and analysis
DE3579856D1 (de) Immunulogischer test zur bestimmung von gemeinsamen, bestimmenden hepatitis-b-antikoerpern.
EP0088974A3 (de) Homogenes immunologisches Verfahren mit markiertem, monoclonalem Antianalyten
DE69200460D1 (de) Agglutinationskomplex zum Nachweis von Blutgruppen.
NZ215143A (en) Immunoassay and test kit for aids
DK161689D0 (da) Multi-immunoassay-system
BR9105983A (pt) Anticorpos monoclonais que diferenciam entre proteinas de sequencias nativa e modificada
SE7904276L (sv) Renat cancerassocierat protein

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties